Natixis Investment Managers International’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,728
Closed -$1.88M 244
2022
Q2
$1.88M Buy
7,728
+2,463
+47% +$604K 0.04% 144
2022
Q1
$1.27M Buy
+5,265
New +$1.21M 0.02% 179
2018
Q4
Sell
-19,330
Closed -$4.01M 45
2018
Q3
$4.01M Buy
19,330
+10,065
+109% +$1.98M 0.19% 82
2018
Q2
$1.71M Buy
9,265
+82
+0.9% +$14.5K 0.09% 161
2018
Q1
$1.57M Buy
9,183
+6,373
+227% +$1.17M 0.11% 115
2017
Q4
$489K Sell
2,810
-6,296
-69% -$1.11M 0.05% 113
2017
Q3
$1.7M Sell
9,106
-2,195
-19% -$389K 0.15% 105
2017
Q2
$1.95M Sell
11,301
-2,089
-16% -$340K 0.17% 87
2017
Q1
$2.2M Buy
13,390
+2,774
+26% +$461K 0.19% 79
2016
Q4
$1.55M Buy
10,616
+2,658
+33% +$400K 0.15% 107
2016
Q3
$1.33M Buy
7,958
+2,334
+42% +$395K 0.14% 101
2016
Q2
$856K Buy
5,624
+335
+6% +$52.1K 0.09% 143
2016
Q1
$793K Buy
5,289
+644
+14% +$95.7K 0.09% 115
2015
Q4
$754K Sell
4,645
-1,145
-20% -$180K 0.1% 112
2015
Q3
$801K Buy
5,790
+76
+1% +$12K 0.11% 132
2015
Q2
$877K Sell
5,714
-98
-2% -$15.7K 0.11% 133
2015
Q1
$929K Sell
5,812
-960
-14% -$151K 0.12% 127
2014
Q4
$1.08M Buy
6,772
+4,075
+151% +$635K 0.14% 113
2014
Q3
$379K Buy
2,697
+1,950
+261% +$255K 0.05% 143
2014
Q2
$88K Buy
747
+45
+6% +$5.21K 0.01% 192
2014
Q1
$87K Sell
702
-2,713
-79% -$329K 0.01% 160
2013
Q4
$390K Hold
3,415
0.07% 115
2013
Q3
$382K Hold
3,415
0.09% 99
2013
Q2
$337K Buy
+3,415
New +$354K 0.08% 92

Other funds holding AMGN

Natixis Investment Managers International's AMGN Position: Q3 2022 in Review

Natixis Investment Managers International sold out of Amgen (AMGN) in Q3 2022, closing a stake of 7,728 shares — an estimated $1.88M sold.

Natixis Investment Managers International first reported a position in AMGN in Q2 2013 and held it in 24 quarters. The position peaked at $4.01M in Q3 2018. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

  • Natixis Investment Managers International reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
  • Natixis Investment Managers International sold 7,728 Amgen shares in Q3 2022, an estimated $1.88M.
  • Natixis Investment Managers International first reported a position in Amgen in Q2 2013 and held it in 24 quarters.
  • Natixis Investment Managers International's Amgen position peaked at $4.01M in Q3 2018.
  • 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.